Task: Answer the multiple choice question.
Query: Which drug exhibits a 3.150% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: Cc1cc(C(C)(C)C)oc1C(=O)N(CC(=O)NC1CCCC1)Cc1ccccc1
b: CCOC(=O)c1cnc(-n2nc(C)cc2C)nc1NC(C)c1ccccc1
Answer: b. CCOC(=O)c1cnc(-n2nc(C)cc2C)nc1NC(C)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1cnc(-n2nc(C)cc2C)nc1NC(C)c1ccccc1
CCOC(=O)c1cnc(-n2nc(C)cc2C)nc1NC(C)c1ccccc1
ethyl 2-(3,5-dimethylpyrazol-1-yl)-4-(1-phenylethylamino)pyrimidine-5-carboxylate